These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 38521954)

  • 1. Vascular leak in sepsis: physiological basis and potential therapeutic advances.
    McMullan RR; McAuley DF; O'Kane CM; Silversides JA
    Crit Care; 2024 Mar; 28(1):97. PubMed ID: 38521954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phosphodiesterase 4 inhibition for treatment of endothelial barrier and microcirculation disorders in sepsis].
    Wollborn J; Schlegel N; Schick MA
    Anaesthesist; 2017 May; 66(5):347-352. PubMed ID: 28429038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microcirculation of the septic kidney.
    Zafrani L; Payen D; Azoulay E; Ince C
    Semin Nephrol; 2015 Jan; 35(1):75-84. PubMed ID: 25795501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 4 inhibition dose dependently stabilizes microvascular barrier functions and microcirculation in a rodent model of polymicrobial sepsis.
    Flemming S; Schlegel N; Wunder C; Meir M; Baar W; Wollborn J; Roewer N; Germer CT; Schick MA
    Shock; 2014 Jun; 41(6):537-45. PubMed ID: 24569506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular resuscitation as a therapeutic goal in severe sepsis.
    Bateman RM; Walley KR
    Crit Care; 2005; 9 Suppl 4(Suppl 4):S27-32. PubMed ID: 16168071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and endothelial dysfunction during sepsis.
    Huet O; Dupic L; Harrois A; Duranteau J
    Front Biosci (Landmark Ed); 2011 Jan; 16(5):1986-95. PubMed ID: 21196278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction: a therapeutic target in bacterial sepsis?
    Vincent JL; Ince C; Pickkers P
    Expert Opin Ther Targets; 2021 Sep; 25(9):733-748. PubMed ID: 34602020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcirculation in sepsis: new perspectives.
    Hernandez G; Bruhn A; Ince C
    Curr Vasc Pharmacol; 2013 Mar; 11(2):161-9. PubMed ID: 23506495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis.
    Alfieri A; Watson JJ; Kammerer RA; Tasab M; Progias P; Reeves K; Brown NJ; Brookes ZL
    Crit Care; 2012 Oct; 16(5):R182. PubMed ID: 23036162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcirculatory dysfunction in sepsis.
    Lundy DJ; Trzeciak S
    Crit Care Clin; 2009 Oct; 25(4):721-31, viii. PubMed ID: 19892249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?
    Lehr HA; Bittinger F; Kirkpatrick CJ
    J Pathol; 2000 Feb; 190(3):373-86. PubMed ID: 10685071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis.
    Rovas A; Seidel LM; Vink H; Pohlkötter T; Pavenstädt H; Ertmer C; Hessler M; Kümpers P
    Crit Care; 2019 Jul; 23(1):260. PubMed ID: 31340868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Activation and Microcirculatory Disorders in Sepsis.
    Raia L; Zafrani L
    Front Med (Lausanne); 2022; 9():907992. PubMed ID: 35721048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfractionated heparin attenuates histone-mediated cytotoxicity in vitro and prevents intestinal microcirculatory dysfunction in histone-infused rats.
    Zhu C; Liang Y; Li X; Chen N; Ma X
    J Trauma Acute Care Surg; 2019 Sep; 87(3):614-622. PubMed ID: 31454337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Endothelial Barrier Dysfunction Caused by Circulating Bacterial and Mitochondrial N-Formyl Peptides With Deformylase.
    Martinez-Quinones P; Komic A; McCarthy CG; Webb RC; Wenceslau CF
    Front Immunol; 2019; 10():1270. PubMed ID: 31244835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness.
    Chappell D; Westphal M; Jacob M
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):155-62. PubMed ID: 19307890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis.
    Zhang H; Wang Y; Qu M; Li W; Wu D; Cata JP; Miao C
    Clin Transl Med; 2023 Jan; 13(1):e1170. PubMed ID: 36629024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial and Microcirculatory Function and Dysfunction in Sepsis.
    Colbert JF; Schmidt EP
    Clin Chest Med; 2016 Jun; 37(2):263-75. PubMed ID: 27229643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of the host microcirculation to bacterial sepsis: does the pathogen matter?
    Legrand M; Klijn E; Payen D; Ince C
    J Mol Med (Berl); 2010 Feb; 88(2):127-33. PubMed ID: 20119709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction.
    Barabutis N; Khangoora V; Marik PE; Catravas JD
    Chest; 2017 Nov; 152(5):954-962. PubMed ID: 28739448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.